Sarafloxacin

Sarafloxacin (INN) is a quinolone antibiotic drug,[1][2] which was removed from clinical use by its manufacturer Abbott Laboratories from April 30, 2001.

Sarafloxacin

Clinical data
AHFS/Drugs.com	International Drug Names
ATCvet code	QJ01MA98 (WHO)
Identifiers
IUPAC name 6-fluoro-1-(4-fluorophenyl)-4-oxo-7-piperazin-1-ylquinoline-3-carboxylic acid
CAS Number	98105-99-8
PubChem CID	56208
ChemSpider	50727
UNII	RC3WJ907XY
ChEMBL	ChEMBL37858
CompTox Dashboard (EPA)	DTXSID8048494
Chemical and physical data
Formula	C20H17F2N3O3
Molar mass	385.371 g·mol^−1
3D model (JSmol)	Interactive image
SMILES Fc1ccc(cc1)N\3c2cc(c(F)cc2C(=O)C(/C(=O)O)=C/3)N4CCNCC4
InChI InChI=1S/C20H17F2N3O3/c21-12-1-3-13(4-2-12)25-11-15(20(27)28)19(26)14-9-16(22)18(10-17(14)25)24-7-5-23-6-8-24/h1-4,9-11,23H,5-8H2,(H,27,28) Key:XBHBWNFJWIASRO-UHFFFAOYSA-N
(what is this?)  (verify)

See also

• Quinolone
• Adverse effects of fluoroquinolones

References

1. "Evaluation of certain veterinary drug residues in food. Fiftieth report of the joint FAO/WHO Expert Committee on Food Additives". World Health Organization Technical Report Series. 888: i–vii, 1–95. 1999. PMID 10416362.
2. Gingerich WH, Stehly GR, Clark KJ, Hayton WL (1998). "Crop grouping: a proposal for public aquaculture". Veterinary and Human Toxicology. 40 Suppl 2: 24–31. PMID 9823579.